NL- LSP portfolio companies Kiadis and Celmed merge to create Kiadis Pharma

Life Sciences Partners (LSP) has announced that, following approval by the shareholders of both companies, the merger between its portfolio companies Kiadis and Celmed has completed. The merger creates Kiadis Pharma BV, an oncology drug development company with four products in various stages of clinical development and a valuable pipeline of early drug candidates. Both Kiadis and Celmed have previously received financial backing from LSP.